Page last updated: 2024-09-05

my 12-62c and piritrexim

my 12-62c has been researched along with piritrexim in 1 studies

Compound Research Comparison

Studies
(my 12-62c)
Trials
(my 12-62c)
Recent Studies (post-2010)
(my 12-62c)
Studies
(piritrexim)
Trials
(piritrexim)
Recent Studies (post-2010) (piritrexim)
41031124216

Protein Interaction Comparison

ProteinTaxonomymy 12-62c (IC50)piritrexim (IC50)
Dihydrofolate reductase Mycobacterium avium0.0006
Dihydrofolate reductaseHomo sapiens (human)0.0024
Dihydrofolate reductaseLacticaseibacillus casei0.0015
Dihydrofolate reductaseSaccharomyces cerevisiae S288C0.031
Dihydrofolate reductaseEscherichia coli K-120.0244
Dipeptidyl peptidase 4Rattus norvegicus (Norway rat)0.011
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.038
Dihydrofolate reductasePneumocystis carinii0.0257
Aromatic-L-amino-acid decarboxylaseHomo sapiens (human)0.0006
Dihydrofolate reductaseCandida albicans0.04
Dipeptidyl peptidase 4Homo sapiens (human)0.014
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.0091
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0043
Bifunctional dihydrofolate reductase-thymidylate synthaseToxoplasma gondii0.0134
Dihydrofolate reductaseRattus norvegicus (Norway rat)0.0031
Dihydrofolate reductase Pneumocystis jirovecii0.041

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boesche, M; Crowther, GJ; Dasari, KS; Drewes, G; El Bakkouri, M; Fox, AM; Ghidelli-Disse, S; He, P; Hillesland, HK; Hui, R; Jones, JC; Keyloun, KR; Krahn, MM; Lafuente-Monasterio, MJ; Leonard, SE; Leroy, D; Maly, DJ; Mo, JS; Ojo, KK; Reid, MC; Rivas, KL; Van Voorhis, WC1

Other Studies

1 other study(ies) available for my 12-62c and piritrexim

ArticleYear
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Antimalarials; Calcium; Cell Line, Tumor; Hep G2 Cells; Humans; Malaria, Falciparum; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Plasmodium falciparum; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protozoan Proteins

2016